WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 28-May-2015 (Data received as of 22-May-2015)
Next overall update July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1'7301 Infant (under 12 months) mortality rate: 182
GDP / capita (US$): 5'2931 Child (under 5 years) mortality rate: 232

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 92'548  91'680  90'796  89'914  89'047  80'888  68'910  54'897 
Births 1'407  1'424  1'440  1'453  1'464  1'403  1'986  1'771 
Surviving infants 1'388  1'404  1'419  1'432  1'442  1'371  1'916  1'695 
Pop. less than 5 years 7'081  7'138  7'184  7'222  7'229  7'128  9'315  8'080 
Pop. less than 15 years 20'895  20'813  20'750  20'777  20'918  25'544  25'778  22'466 
Female 15-49 years 26'061  26'043  26'003  25'910  25'752  22'125  16'867  12'486 

Number of reported case

(Click for retrospective incidence data for Viet Nam)
Diphtheria 16  11  12  13  113  509  1'730 
Japanese encephalitis 421  224  183  126  140 
Measles 15'033  1'123  578  750  2'809  16'512  8'175  86'901 
Mumps
Pertussis 90  54  98  105  81  1'426  4'095  96'577 
Polio* 723  1'741 
Rubella 59  54  185  7'259  2'300 
Rubella (CRS) 92  189 
Tetanus (neonatal) 34  46  39  32  35  142  313 
Tetanus (total)** 244  306  253  186  196  267  628  1'948 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Viet Nam)
Vaccine year result method % card seen                                                
BCG 2009  96  MICS   52  96  95  98  98  94  98  90 
DTP1 2009  94  MICS   52  95  83  99  97  93  97 
DTP3 2009  74  MICS   52  95  59  97  95  93  96  88 
HepB_BD          55  56  76  55  21 
HepB3 2009  56  MICS   52  95  59  97  95  88  94 
Hib3          95  59  97  95  63 
JapEnc          94  91  94  93 
MCV          97  98  96  96  98  97  88 
MCV2          94  86  83  93  98 
PCV1         
PCV3         
Pol3 2009  69  MICS   52  96  93  97  96  94  96  88 
Rota1         
Rota_last         
Rubella1         
TT2plus 2001  71  DHS   40  91  91  95  95  90  90  22 
PAB         
VAD1          86  80  98  80  90  77 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Viet Nam)
BCG 95  98  98  94  98  90 
DTP1 83  99  97  93  97  96 
DTP3 59  97  95  93  96  88 
HepB3 59  97  95  88 
HepB_BD 44  64  43 
Hib3 59  97  95  63 
MCV 98  96  96  98  97  88 
MCV2 86  83  93  98 
PAB 91  91  87  87  86  24 
PCV3
Pol3 93  97  96  94  96  88 
Rota_last

Number of districts in the country 704  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 88
From 80 to 89% 7
From 50 to 79% 5
Less than 50% 1
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
CHOLERA No
DTwP 18 months; Yes
DTwPHibHepB 2, 3, 4 months; Yes
HepB_Pediatric birth; Yes
JapEnc 12 months; + 2 weeks; 2 years; No
Measles 9, 18 months; Yes
OPV 2, 3, 4 months; Yes
TT pregnant Women; +1, +6 months; +1 year; Yes
Typhoid 3 years; No
VitaminA 6-11, 12-17, 18-23, 24-29, 30-36 months; Yes and pregnant women

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2011-2015  2011-2015  2006 - 2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number     10     

System performance

Total Nº districts in country number 704  698  697  696  695  690  684 
Nº districts with DTP3 coverage >=80% number 662  100  676  657  662  668  666 
% of districts with DTP3 coverage >=80% From 0 to 100% 94  14  97  94  95  97  97 
Nº districts with measles (MCV1) coverage >=95% number 551  557  532  532  585  558  590 
% of districts with MCV1 coverage >=95% From 0 to 100% 78  80  76  76  84  81  86 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%   40  36  33  39  85  70 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.